Stifel strives for a culture that puts its clients and associates first: a culture where everyone belongs, everyone is welcome, and everyone contributes to the success of our clients, their careers, and the firm as a whole.
Let’s talk about how you can find your place here at Stifel, where success meets success.
What You'll Be DoingUnder general supervision, the Research Associate III is primarily responsible for evaluating biotechnology therapeutic pipelines and competitive landscapes by analyzing data presentations and scientific literature, performing financial modeling, and providing organizational support to the senior level Research Analyst. The ideal candidate possesses high-level knowledge of oncology and/or immunology concepts. At this level, the associate should demonstrate proficiency in data analysis, competitive landscape diligence, and the basics of financial modeling. The role requires the ability to communicate complex scientific concepts in a clear and concise manner both orally and in writing.
What We're Looking For- Conduct proprietary research to evaluate drug pipelines by analyzing scientific literature, attending medical conferences, and speaking with key opinion leaders.
- Build and maintain Excel-based financial models, including income statements, balance sheets, cash flow statements, and drug revenue models.
- Written contribution to research reports for initiations of coverage, analysis of data, and company news.
- Build and maintain drug/indication competitive landscape analyses.
- Clearly state and defend the Analyst's investment thesis and outlook for each of the stocks under coverage.
- Respond to basic questions from institutional sales and clients regarding covered companies, industry trends, and data requests.
- Demonstrate the ability to work independently and use all resources to identify and locate relevant research materials.
- Continuously develop industry knowledge and stay up to date on industry news flow.
- High level understanding of scientific concepts related to drug mechanism of action and clinical endpoints - ability to analyze and draw novel conclusions from medical literature and clinical/pre-clinical data presentations.
- Inductive Reasoning - The ability to combine pieces of information to form general rules or conclusions.
- Critical Thinking - Using logic and reasoning to identify the strengths and weaknesses of alternative solutions, conclusions or approaches to problems.
- Judgment and Decision Making - Considering the relative costs and benefits of potential actions to choose the most appropriate one.
- Time Management - Managing one's own time and priorities to ensure the meeting of deadlines.
- Oral and Written Expression - The ability to communicate information and ideas in spoken or written form effectively.
- Minimum Required: Bachelor's degree in the biomedical STEM field, Masters or higher degree in relevant field preferred
- Minimum Required: 4 years of experience in biotech equity research or oncology focused healthcare consulting
- Minimum Required: SIE, Series 63, 86, and 87 expected to be obtained upon hire
- Proficient in Microsoft Excel, Word, PowerPoint, Outlook
The Stifel Equity Research Group is a recognized leader with a deep and broad spectrum of coverage. Our award-winning analysts are thought leaders, many with hands-on experience in their respective industries, offering objective, in-depth analysis and timely, actionable research ideas.
Stifel is a top 10 provider of U.S. equity coverage in:
- Aerospace & Defense
- Consumer & Retail
- Diversified Industrials
- Internet & Media
- Healthcare
- Real Estate
- Technology
- Transportation
- Business Services
- Energy & Power
- Materials
Skills Required
- Bachelor's degree in a biomedical STEM field
- Master's degree or higher in a relevant field
- Four years of experience in biotech equity research or oncology-focused healthcare consulting
- High-level understanding of drug mechanisms of action, clinical endpoints, medical literature, and clinical or preclinical data
- SIE, Series 63, Series 86, and Series 87 licenses expected to be obtained upon hire
- Proficiency in Microsoft Excel, Word, PowerPoint, and Outlook
- Ability to communicate complex scientific concepts clearly in writing and orally
Stifel Financial Corp. Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Stifel Financial Corp. and has not been reviewed or approved by Stifel Financial Corp..
-
Strong & Reliable Incentives — Compensation is positioned as highly attractive for financial advisors, with emphasis on meaningful earning upside tied to production. Recognition for advisor satisfaction indicates that incentive mechanics can be a differentiator in producer roles.
-
Flexible Benefits — The benefits program is broad and multi-option, spanning multiple health plan choices, FSAs/HSAs, and a wide set of voluntary insurance add-ons. This menu-style design supports tailoring coverage to different life stages and needs.
-
Parental & Family Support — Family-oriented benefits are extensive, including parental leave, adoption assistance, fertility and family-building support, and back-up childcare and elder care. These offerings signal a comparatively strong support system for caregiving and family planning.
Stifel Financial Corp. Insights
What We Do
Established in 1890, Stifel, Nicolaus & Company, Incorporated is one of the nation’s premier full-service financial services firms, providing brokerage, trading, investment banking, investment advisory, and related services to individual investors, professional money managers, businesses, and municipalities through more than 400 locations across the U.S. Stifel ranks as the 7th largest brokerage firm in the country as measured by number of financial advisors, with approximately 2,300, and features a highly regarded equity research department that has earned numerous accolades from such publications as The Wall Street Journal, Forbes, and the Financial Times. In 2023 and 2024, Stifel was recognized as the No. 1 wealth management firm for employee advisor satisfaction, based on the J.D. Power U.S. Financial Advisor Satisfaction Study*. Stifel is the principal subsidiary of Stifel Financial Corp. (NYSE: SF), a financial services holding company headquartered in St. Louis, Missouri. Stifel Financial Corp.'s other subsidiaries include Stifel Independent Advisors, LLC, an independent contractor broker-dealer firm; Stifel Nicolaus Europe Limited, the Company’s European subsidiary; Stifel Nicolaus Canada, Inc., our Canadian subsidiary; Stifel Bank and Trust and Stifel Bank, retail and commercial banks; and Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A, our trust companies. *Stifel received the highest score among employee advisors in the J.D. Power 2023-2024 U.S. Financial Advisor Satisfaction Studies, which measures employee advisors’ satisfaction among those who are employed by an investment services firm. Visit jdpower.com/awards for more details.
